Gefen Capital is a US-Israeli venture capital firm founded in 2016 and headquartered in Herzliya, Israel. See contact routes.
Gefen Capital is a US-Israeli venture capital firm founded in 2016 and headquartered in Herzliya, Israel, with additional offices in Dallas and Boston. The firm targets early-stage Israeli startups developing disruptive technologies, primarily investing in the Seed, Series A, and Series B stages across sectors including HealthTech, FinTech, AgTech, and Software. Its typical check size ranges from $1 million to $3 million, and it operates as a stage-agnostic investor within that range, often taking lead or significant follow positions. Notable portfolio companies include EarlySense, Capitalise, Rapid Medical, and Douxmatok, which span medical technology, financial infrastructure, emergency care, and food innovation. Gefen distinguishes itself through a flexible investment strategy with no fixed deadlines for investing or exiting, leveraging its principals’ operational experience and strong US network to help Israeli startups scale in the American market. The firm emphasizes backing US-facing companies with strong technological differentiation and access to large markets, rather than adhering to a rigid sector or geography mandate.
This profile is part of the StartupFundraising firm database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find comparable investors.
Investors like Gefen Capital · Full investor directory · Investor access · Company funding database